[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  alphavestcapital.com [@alphavestcap](/creator/twitter/alphavestcap) on x 1870 followers Created: 2025-07-13 16:20:46 UTC @alphavestcap Jul X Show moreLook what was said on the webpage. It must have something to do with $N. Otherwise $N would have a tough competitor. Dendritic Cell Vaccine Allogeneic tumor lysates with classic GBM antigens and autologous dendritic cells capable of inducing an@alphavestcap$nwbo · Show morehttps://x.com/alphavestcap/status/1943855704143532291 · Show more$NW still has to go through IFR validation and labeling. Even though approval may be imminent, real access does not start the moment the authorization is granted. First, MHRA has to finalize and publish the label and SmPC. That defines who the treatment is for, how it is http://alphavestcapital.com@alphavestcap· Jul X Show morehttps://x.com/d_stock07734/status/1942746439861338298 $nw d_stock@d_stock07734Quoted_stock@d_stock07734·Jul 10Show moreAbstract 6750: Validation of a platform to develop new dendritic cell vaccines for cancer immunotherapy Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Phase I trial of adjuvant matureLast edited11:57 AM · Jul 13, 2025·Views53View post engagements  XX engagements  **Related Topics** [$nwboalphavestcapquote](/topic/$nwboalphavestcapquote) [$nwbo](/topic/$nwbo) [$n](/topic/$n) [Post Link](https://x.com/alphavestcap/status/1944431821732851907)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
alphavestcapital.com @alphavestcap on x 1870 followers
Created: 2025-07-13 16:20:46 UTC
@alphavestcap Jul X Show moreLook what was said on the webpage. It must have something to do with $N. Otherwise $N would have a tough competitor. Dendritic Cell Vaccine Allogeneic tumor lysates with classic GBM antigens and autologous dendritic cells capable of inducing an@alphavestcap$nwbo · Show morehttps://x.com/alphavestcap/status/1943855704143532291 · Show more$NW still has to go through IFR validation and labeling. Even though approval may be imminent, real access does not start the moment the authorization is granted. First, MHRA has to finalize and publish the label and SmPC. That defines who the treatment is for, how it is http://alphavestcapital.com@alphavestcap· Jul X Show morehttps://x.com/d_stock07734/status/1942746439861338298 $nw
d_stock@d_stock07734Quoted_stock@d_stock07734·Jul 10Show moreAbstract 6750: Validation of a platform to develop new dendritic cell vaccines for cancer immunotherapy Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Phase I trial of adjuvant matureLast edited11:57 AM · Jul 13, 2025·Views53View post engagements
XX engagements
Related Topics $nwboalphavestcapquote $nwbo $n
/post/tweet::1944431821732851907